Bupropion Extended Release Oral Tablet
FMCH-2019-28219
Approved small_molecule active
Quick answer
Bupropion Extended Release Oral Tablet for Postpartum Smoking Relapse is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Postpartum Smoking Relapse
- Phase
- Approved
- Modality
- small_molecule
- Status
- active